Can immune reprogramming with alemtuzumab induce permanent remission in multiple sclerosis?

Heinz Wiendl, Dennis Bourdette, Olga Ciccarelli

Research output: Contribution to journalEditorial

8 Scopus citations
Original languageEnglish (US)
Pages (from-to)1098-1100
Number of pages3
JournalNeurology
Volume89
Issue number11
DOIs
StatePublished - Sep 1 2017
Externally publishedYes

ASJC Scopus subject areas

  • Clinical Neurology

Cite this